Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Metagenomi (MGX) Equity Ratio (2023 - 2025)

Metagenomi (MGX) has disclosed Equity Ratio for 3 consecutive years, with 0.72 as the latest value for Q4 2025.

  • On a quarterly basis, Equity Ratio fell 0.86% to 0.72 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.72, a 0.86% decrease, with the full-year FY2025 number at 0.72, down 0.86% from a year prior.
  • Equity Ratio was 0.72 for Q4 2025 at Metagenomi, roughly flat from 0.72 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.72 in Q4 2024 to a low of 0.37 in Q4 2023.
  • A 3-year average of 0.59 and a median of 0.71 in 2025 define the central range for Equity Ratio.
  • Peak YoY movement for Equity Ratio: soared 294.69% in 2024, then fell 0.86% in 2025.
  • Metagenomi's Equity Ratio stood at 0.37 in 2023, then skyrocketed by 294.69% to 0.72 in 2024, then fell by 0.86% to 0.72 in 2025.
  • Per Business Quant, the three most recent readings for MGX's Equity Ratio are 0.72 (Q4 2025), 0.72 (Q3 2025), and 0.72 (Q2 2025).